The in vivo pharmacodynamic data provided clear evidence that a single administration of of BD-9136 was remarkably efficient in causing a highly efficent and sustained reduction of BRD4 protein levels, specifically within tumor tissues. The gene discussed is BRD4; the disease is neoplasm.